Dan Gusenleitner

I am passionate about leveraging data and cutting-edge technologies to improve cancer drug development and advance personalized medicine—matching the right patients with the right treatments. Throughout my career, I’ve collaborated with clinical teams to champion data-driven decision-making.

My personal experiences with cancer drive my commitment to developing knowledge systems that integrate clinical, imaging, and biomarker data. These systems provide real-time access to high-quality information, enhancing our ability to make timely, informed decisions. I believe that by harnessing comprehensive cancer data, we can deepen our understanding of cancer biology and drug mechanisms while minimizing potential side effects.

Ultimately, curing cancer is a team effort requiring diverse expertise and leadership founded not just on vision, but on empathy that recognizes the human behind each patient.